Kerion Celsi due to Microsporum canis in an Adult Woman, Treated Successfully with Fosravuconazole.

IF 1.4 Q4 MYCOLOGY
Harunari Shimoyama, Haruka Taira, Kazuo Satoh, Takashi Tamura, Ayaka Yo, Yoshihiro Sei, Koichi Makimura, Yoshihiro Kuwano
{"title":"Kerion Celsi due to Microsporum canis in an Adult Woman, Treated Successfully with Fosravuconazole.","authors":"Harunari Shimoyama,&nbsp;Haruka Taira,&nbsp;Kazuo Satoh,&nbsp;Takashi Tamura,&nbsp;Ayaka Yo,&nbsp;Yoshihiro Sei,&nbsp;Koichi Makimura,&nbsp;Yoshihiro Kuwano","doi":"10.3314/mmj.22-00025","DOIUrl":null,"url":null,"abstract":"<p><p>A 64-year-old woman presented with a fist-sized, severely painful lesion with scales, crusts, pustules, erythema with subcutaneous abscess, and hair loss on the left temporal region. Direct microscopic examination revealed a large number of spores around the hair, which indicated ectothrix hair invasion, and some hyphae were also found. Histopathological examination showed significant inflammatory cell infiltration from the dermis to the subcutaneous tissues and into the hair follicles, destruction of the hair follicles with granulomatous reactions, and fungal masses along the hair within the hair follicles. Microsporum canis was identified based on morphological features via culture method and molecular biological analysis of the internal transcribed spacer region DNA sequence. The patient was diagnosed with kerion celsi caused by M. canis. For treatment of kerion celsi, we chose an oral antifungal agent, fosravuconazole (FRVCZ), which has been available since 2018 only in Japan. Clinical symptoms were cured in 12 weeks without scarring. No side effects were observed during oral administration of FRVCZ. The results of our case and several previous reports suggest that FRVCZ is effective in treating various types of dermatomycoses.</p>","PeriodicalId":18325,"journal":{"name":"Medical mycology journal","volume":null,"pages":null},"PeriodicalIF":1.4000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medical mycology journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3314/mmj.22-00025","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"MYCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

A 64-year-old woman presented with a fist-sized, severely painful lesion with scales, crusts, pustules, erythema with subcutaneous abscess, and hair loss on the left temporal region. Direct microscopic examination revealed a large number of spores around the hair, which indicated ectothrix hair invasion, and some hyphae were also found. Histopathological examination showed significant inflammatory cell infiltration from the dermis to the subcutaneous tissues and into the hair follicles, destruction of the hair follicles with granulomatous reactions, and fungal masses along the hair within the hair follicles. Microsporum canis was identified based on morphological features via culture method and molecular biological analysis of the internal transcribed spacer region DNA sequence. The patient was diagnosed with kerion celsi caused by M. canis. For treatment of kerion celsi, we chose an oral antifungal agent, fosravuconazole (FRVCZ), which has been available since 2018 only in Japan. Clinical symptoms were cured in 12 weeks without scarring. No side effects were observed during oral administration of FRVCZ. The results of our case and several previous reports suggest that FRVCZ is effective in treating various types of dermatomycoses.

成年女性犬小孢子虫引起的角状细胞瘤用福司伐康唑治疗成功。
一名64岁女性,表现为拳头大小的严重疼痛病变,伴有鳞片、结痂、脓疱、红斑伴皮下脓肿和左侧颞区脱发。直接镜下观察毛周围有大量孢子,提示外生蓟马毛侵入,并发现一些菌丝。组织病理学检查显示,从真皮到皮下组织和毛囊有明显的炎症细胞浸润,毛囊被肉芽肿反应破坏,毛囊内沿头发有真菌团块。通过培养法和内部转录间隔区DNA序列的分子生物学分析,鉴定了犬小孢子菌的形态特征。诊断为犬分枝杆菌所致的角质瘤。为了治疗角细胞,我们选择了口服抗真菌剂fosravuconazole (FRVCZ),该药物自2018年起仅在日本上市。临床症状12周治愈,无瘢痕形成。口服FRVCZ期间未观察到副作用。本病例的结果和先前的一些报告表明,FRVCZ对治疗各种类型的皮肤霉菌病有效。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Medical mycology journal
Medical mycology journal Medicine-Infectious Diseases
CiteScore
1.80
自引率
10.00%
发文量
16
期刊介绍: The Medical Mycology Journal is published by and is the official organ of the Japanese Society for Medical Mycology. The Journal publishes original papers, reviews, and brief reports on topics related to medical and veterinary mycology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信